India withdraws pharma pricing regulator's power to cap non-essential drug prices

Image
Reuters MUMBAI
Last Updated : Sep 23 2014 | 11:15 AM IST

MUMBAI (Reuters) - India has withdrawn the drug pricing authority's powers that allowed it to fix the prices of medicines not deemed essential, after its decision to impose price caps on more than 100 drugs in July triggered industry protests.

The Department of Pharmaceuticals has withdrawn guidelines issued on May 29 that gave the National Pharmaceutical Pricing Authority (NPPA) the powers to fix the prices of drugs that are not on the essential medicines list, the latter said in a notice late on Monday.

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, directly controls the NPPA.

The NPPA had issued a notice in July imposing price caps on 108 non-essential drugs, which are used to treat diseases ranging from diabetes to HIV/AIDS. The move has been challenged by the industry lobby groups in courts.

(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 23 2014 | 11:10 AM IST

Next Story